Aditxt, Inc. (ADTX)
Largest Insider Buys in Sector
ADTX Stock Price History Chart
ADTX Stock Performance
About Aditxt, Inc.
Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. It develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its own tissues. The company is also developing ADi products for organ transplantation, including skin grafting, autoimmune diseases, and allergies. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Richmond, Virginia.
Insider Activity of Aditxt, Inc.
Over the last 12 months, insiders at Aditxt, Inc. have bought $23,454 and sold $29,875 worth of Aditxt, Inc. stock.
On average, over the past 5 years, insiders at Aditxt, Inc. have bought $37,727 and sold $360,508 worth of stock each year.
Highest buying activity among insiders over the last 12 months: HRT FINANCIAL LP (10 percent owner) — $23,454.
The last purchase of 15,636 shares for transaction amount of $23,454 was made by HRT FINANCIAL LP (10 percent owner) on 2024‑10‑15.
List of Insider Buy and Sell Transactions, Aditxt, Inc.
| 2024-10-16 | Sale | 10 percent owner | 25,534 2.5257% | $1.17 | $29,875 | -68.66% | ||
| 2024-10-15 | 10 percent owner | 15,636 1.9829% | $1.50 | $23,454 | -68.92% | |||
| 2023-09-07 | Sale | 20,800 12.7911% | $33.23 | $691,140 | -88.24% | |||
| 2022-07-19 | Chief Executive Officer | 1 – | $20,000.00 | $20,000 | -84.78% | |||
| 2021-06-01 | CHIEF INNOVATION OFFICER | 490 0.0034% | $2.93 | $1,436 | -64.24% | |||
| 2021-06-01 | CHIEF OPERATING OFFICER | 3,400 0.0238% | $2.93 | $9,974 | -64.24% | |||
| 2021-06-01 | CHIEF EXECUTIVE OFFICER | 3,400 0.0238% | $2.93 | $9,974 | -64.24% | |||
| 2021-06-01 | director | 10,000 0.07% | $2.93 | $29,344 | -64.24% | |||
| 2021-05-27 | CHIEF INNOVATION OFFICER | 185 0.0013% | $2.70 | $500 | -59.62% | |||
| 2021-05-26 | PRINCIPAL ACCOUNTING OFFICER | 2,500 0.0172% | $2.68 | $6,700 | -59.70% | |||
| 2021-05-25 | CHIEF INNOVATION OFFICER | 417 0.0026% | $2.39 | $998 | -58.65% | |||
| 2021-05-25 | CHIEF FINANCIAL OFFICER | 4,220 0.0279% | $2.56 | $10,803 | -58.65% |
Insider Historical Profitability
| HRT FINANCIAL LP | 10 percent owner | 0 0% | $0.13 | 1 | 1 | |
| Shabahang Shahrokh | CHIEF INNOVATION OFFICER | 1016098 7.1384% | $0.13 | 3 | 0 | |
| Albanna Rowena | CHIEF OPERATING OFFICER | 751620 5.2804% | $0.13 | 1 | 0 | |
| Pankovcin Corinne | CHIEF FINANCIAL OFFICER | 114220 0.8024% | $0.13 | 1 | 0 | |
| BNP PARIBAS SECURITIES CORP | 22342 0.157% | $0.13 | 0 | 1 | ||
| Runge Jeffrey W. | director | 12500 0.0878% | $0.13 | 1 | 0 | |
| Farley Thomas J | PRINCIPAL ACCOUNTING OFFICER | 2500 0.0176% | $0.13 | 1 | 0 | |
| Albanna Amro A. | Chief Executive Officer | 1 0% | $0.13 | 2 | 0 | <0.0001% |